A Phase 2 Randomized Study of LY2541546 Versus Placebo in Postmenopausal Women With Low Bone Mineral Density: An Evaluation of the Dose Response Relationship Using Bone Mineral Density.
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Blosozumab (Primary)
- Indications Bone resorption; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 29 Mar 2015 Efficacy results related to baseline demographics presented at the 2015 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
- 05 Oct 2013 Spine and hip strength results (n=42) presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History